# Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?

> **NCT07012356** · — · COMPLETED · sponsor: **Necmettin Erbakan University** · enrollment: 95 (actual)

## Conditions studied

- Colposcopy
- HPV
- HSIL

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07012356
- **Lead sponsor:** Necmettin Erbakan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-01
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07012356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07012356, "Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07012356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*